Kerstin Herzer

Bad Neuenahr, RP 53474, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Early Conversion to Once-Daily MeltDose® Extended-Release Tacrolimus (LCPT) in Liver Transplant Patients.

Early Conversion to Once-Daily MeltDose® Extended-Release Tacrolimus (LCPT) in Liver Transplant Patients.

Journal: Journal of clinical medicine

Published: September 16, 2025

Effectiveness of a Personal Vaccination Recommendation Letter to Liver Transplant Patients and Family Physicians for Improving the Vaccination Status: Improving Vaccinations: Whom to Contact?

Effectiveness of a Personal Vaccination Recommendation Letter to Liver Transplant Patients and Family Physicians for Improving the Vaccination Status: Improving Vaccinations: Whom to Contact?

Journal: Clinical transplantation

Published: January 08, 2025

Declining Numbers of Hepatitis C Virus-Associated Liver Transplantations in Germany.

Declining Numbers of Hepatitis C Virus-Associated Liver Transplantations in Germany.

Journal: Deutsches Arzteblatt international

Published: May 31, 2021

Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients.

Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients.

Journal: Vaccines

Published: December 17, 2020

Real-World Administration of Once-Daily MeltDose® Prolonged-Release Tacrolimus (LCPT) Allows for Dose Reduction of Tacrolimus and Stabilizes Graft Function Following Liver Transplantation.

Real-World Administration of Once-Daily MeltDose® Prolonged-Release Tacrolimus (LCPT) Allows for Dose Reduction of Tacrolimus and Stabilizes Graft Function Following Liver Transplantation.

Journal: Journal of clinical medicine

Published: October 28, 2020

Current Challenges in the Post-Transplant Care of Liver Transplant Recipients in Germany.

Current Challenges in the Post-Transplant Care of Liver Transplant Recipients in Germany.

Journal: Journal of clinical medicine

Published: September 24, 2020

Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers.

Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers.

Journal: Journal of clinical medicine

Published: June 26, 2020

Safety and efficacy of tenofovir alafenamide in liver transplant recipients: A single center experience.

Safety and efficacy of tenofovir alafenamide in liver transplant recipients: A single center experience.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: May 12, 2020

HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level.

HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level.

Journal: BMC gastroenterology

Published: April 16, 2020

Primary sclerosing cholangitis as an independent risk factor for cytomegalovirus infection after liver transplant.

Primary sclerosing cholangitis as an independent risk factor for cytomegalovirus infection after liver transplant.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: February 24, 2020

Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral therapy-Results from the German Hepatitis C-Registry.

Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral therapy-Results from the German Hepatitis C-Registry.

Journal: Journal of viral hepatitis

Published: August 12, 2019

Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients.

Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: May 23, 2019

Showing 1-12 of 56

Last Updated: 09/26/2026